Delayed cardiac toxicity from anthracycline therapy.

Laurel J. Steinherz, P. Steinherz

PubMed · 1991 · 60 citations · 0 references

Concepts

Abstract

Survivors of childhood cancer who received anthracycline treatment have a high incidence of abnormal cardiac function. Cardiac decompensation and death can appear many years after completion of chemotherapy. These survivors require periodic evaluation of cardiac function and rhythm.